Could a simple sugar protect bone marrow transplant patients?
NCT ID NCT04263597
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a sugar called 2'-fucosyllactose (2FL) is safe and can help maintain gut health in 70 people receiving a bone marrow transplant. The goal was to see if it reduces infections and a complication called graft-versus-host disease. Participants took the supplement by mouth, and researchers measured changes in gut bacteria and markers of inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL TRANSPLANT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Real-World data unlock clues to a deadly Post-Transplant complication?
- Can talking about meaning help stem cell transplant recovery?
- Heart prep: 8-Week home workout may shield stem cell patients
- Step up: a new program aims to boost daily steps and reduce disability in blood cancer survivors.
- Could a targeted drug make stem cell transplants more effective for tough blood cancers?
- Happiness therapy: new study aims to ease anxiety in transplant survivors